Atlas Trials

A Safety, Tolerability, Pharmacokinetic/Pharmacodynamic Study, and QT Interval Study of HRS-5965 Capsules in Healthy Subjects

Clinical trial NCT06684041 · COMPLETED

Trial details

NCT number
NCT06684041
Sponsor
Chengdu Suncadia Medicine Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hemolytic Anemia
Start date
2024-11-09
Primary completion
2025-04-07
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.